Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Charles Nolan Parker currently holds 90,000 shares of Traws Pharma, Inc. (TRAW), valued at approximately $0. This represents their equity stake as Chief Financial Officer.
Based on SEC Form 4 filings, Charles Nolan Parker has been a net neutral trader of TRAW stock. They have purchased $0 and sold $0 worth of shares.
Charles Nolan Parker's most recent insider trade was on Jul 9, 2026, when they sold 90,000 shares at $0.00 per share.
Charles Nolan Parker serves as Chief Financial Officer at Traws Pharma, Inc. (TRAW). They have executed 5 insider transactions totaling $0 over their tenure at the company.
Charles Nolan Parker holds the position of Chief Financial Officer at Traws Pharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Charles Nolan Parker has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Charles Nolan Parker was on Jul 9, 2026, when they purchased $0 worth of TRAW shares. This transaction involved 90,000 shares at N/A per share.
Charles Nolan Parker currently owns 90,000 shares of Traws Pharma, Inc. (TRAW), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Charles Nolan Parker's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Charles Nolan Parker has 5 Form 4 filings on record as an insider at Traws Pharma, Inc..
Set alerts for Charles Nolan Parker and 40,000+ other insiders.